| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Orlando Matthew | General Counsel | 1 KENVUE WAY, SUMMIT | /s/ Alla Berenshteyn, as attorney-in-fact | 17 Dec 2025 | 0001967444 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | KVUE | Common Stock | Options Exercise | $0 | +10,579 | +37% | $0.000000 | 39,418 | 15 Dec 2025 | Direct | |
| transaction | KVUE | Common Stock | Tax liability | $112,216 | -6,494 | -16% | $17.28 | 32,924 | 15 Dec 2025 | Direct | F1 |
| transaction | KVUE | Common Stock | Options Exercise | $0 | +1,370 | +4.2% | $0.000000 | 34,294 | 15 Dec 2025 | Direct | |
| transaction | KVUE | Common Stock | Tax liability | $14,532 | -841 | -2.5% | $17.28 | 33,453 | 15 Dec 2025 | Direct | F1 |
| transaction | KVUE | Common Stock | Options Exercise | $0 | +6,361 | +19% | $0.000000 | 39,814 | 15 Dec 2025 | Direct | |
| transaction | KVUE | Common Stock | Tax liability | $67,205 | -3,905 | -9.8% | $17.21 | 35,909 | 15 Dec 2025 | Direct | F1 |
| transaction | KVUE | Common Stock | Options Exercise | $0 | +5,611 | +16% | $0.000000 | 41,520 | 15 Dec 2025 | Direct | |
| transaction | KVUE | Common Stock | Tax liability | $59,288 | -3,445 | -8.3% | $17.21 | 38,075 | 15 Dec 2025 | Direct | F1, F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | KVUE | Restricted Stock Units | Options Exercise | $0 | -10,579 | -100% | $0.000000 | 0 | 15 Dec 2025 | Common Stock | 10,579 | Direct | F3, F4, F5 | |
| transaction | KVUE | Restricted Stock Units | Options Exercise | $0 | -1,370 | -100% | $0.000000 | 0 | 15 Dec 2025 | Common Stock | 1,370 | Direct | F5, F6, F7 | |
| transaction | KVUE | Restricted Stock Units | Options Exercise | $0 | -6,361 | -50% | $0.000000 | 6,360 | 15 Dec 2025 | Common Stock | 6,361 | Direct | F2, F5, F8, F9 | |
| transaction | KVUE | Restricted Stock Units | Options Exercise | $0 | -5,611 | -33% | $0.000000 | 11,221 | 15 Dec 2025 | Common Stock | 5,611 | Direct | F2, F5, F8, F10 |
| Id | Content |
|---|---|
| F1 | Shares withheld for payment of taxes upon vesting of Restricted Share Units (RSUs). |
| F2 | Includes shares acquired in dividend reinvestment transactions. |
| F3 | These RSUs were originally granted by Johnson & Johnson as performance share units and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 2023, were converted into time-based RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value and with performance criteria deemed satisfied at the target level. |
| F4 | This award was scheduled to vest in full on 2/13/2026, subject to the reporting person's continued service through the vesting date but vesting was accelerated in order to mitigate the adverse impact to the Issuer and the Reporting Person of Section 280G of the Internal Revenue Code in connection with the pending transaction between the Issuer and Kimberly-Clark Corporation ("Section 280G Mitigation"). |
| F5 | This award will be subject to clawback in the event it is determined that the Reporting Person would not have ultimately vested in the award notwithstanding the acceleration reflected herein. |
| F6 | These RSUs were originally granted by Johnson & Johnson and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 20223 and pursuant to the terms of the Employee Matters Agreement, dated as of May 3, 2023 between Johnson & Johnson and the Issuer, were converted into RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value. |
| F7 | This award was scheduled to vest in three equal installments on 02/13/2024, 02/13/2025, and 02/13/2026, subject to the reporting person's continued service through the vesting date but the vesting of the portion reflected herein was accelerated from 02/13/2026 in connection with the Section 280G Mitigation. |
| F8 | These units correspond 1 for 1 with the Company's common stock. |
| F9 | This award was scheduled to vest in three equal installments on 03/05/2025, 03/05/2026, and 03/05/2027, subject to the reporting person's continued service through such vesting date but the vesting of the portion reflected herein was accelerated from 03/05/2026 in connection with the 280G Mitigation. |
| F10 | This award was scheduled to vest in three equal installments on 03/10/2026, 03/10/2027, and 03/10/2028, subject to the reporting person's continued service through such vesting date but the vesting of the portion reflected herein was accelerated from 03/10/2026 in connection with the Section 280G Mitigation. |